Page last updated: 2024-08-21

quinazolines and ruthenium

quinazolines has been researched along with ruthenium in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's9 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Du, Z; Hao, X; Ji, L; Li, X; Lin, Y; Lü, S; Luo, Q; Wang, F; Wang, X; Yang, L; Yu, Y; Zhao, Y; Zheng, W1
Hao, X; Ji, L; Li, X; Lin, Y; Lü, S; Luo, Q; Wang, F; Wang, X; Yang, L; Zheng, W1
Liu, S; Luo, Q; Wang, F; Zhang, E; Zhang, Y; Zhao, Y; Zheng, W1
Cajaraville, A; López, S; Saá, C; Suárez, J; Varela, JA1
Du, J; Lin, Y; Luo, Q; Wang, F; Wang, Z; Wu, K; Zhang, E; Zhang, Y; Zhao, Y; Zheng, W1
Du, J; Kang, Y; Lin, Y; Luo, Q; Wang, F; Wang, Y; Wang, Z; Wu, K; Zhang, Y; Zhao, Y; Zheng, W1
Feng, NP; He, ZH; Li, YY; Shen, LN; Wang, Z; Xia, Q; Zhang, YT1
Kirinde Arachchige, PT; Yi, CS1
Christou, YA; Dietis, N; Georgiades, SN; Ilmi, R; Odysseos, AD; Pitris, C; Stylianou, P; Tseriotou, E; Ttofi, I1

Other Studies

9 other study(ies) available for quinazolines and ruthenium

ArticleYear
Complexation with organometallic ruthenium pharmacophores enhances the ability of 4-anilinoquinazolines inducing apoptosis.
    Chemical communications (Cambridge, England), 2013, Nov-11, Volume: 49, Issue:87

    Topics: Aniline Compounds; Antineoplastic Agents; Apoptosis; Cell Proliferation; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; ErbB Receptors; Humans; Hydrolysis; MCF-7 Cells; Models, Molecular; Molecular Structure; Organometallic Compounds; Quinazolines; Ruthenium; Structure-Activity Relationship

2013
Novel ruthenium complexes ligated with 4-anilinoquinazoline derivatives: synthesis, characterisation and preliminary evaluation of biological activity.
    European journal of medicinal chemistry, 2014, Apr-22, Volume: 77

    Topics: Aniline Compounds; Antineoplastic Agents; Apoptosis; Cell Proliferation; Cell Survival; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; ErbB Receptors; Gefitinib; Humans; MCF-7 Cells; Models, Molecular; Molecular Structure; Organometallic Compounds; Quinazolines; Ruthenium; Structure-Activity Relationship

2014
Dual-targeting organometallic ruthenium(II) anticancer complexes bearing EGFR-inhibiting 4-anilinoquinazoline ligands.
    Dalton transactions (Cambridge, England : 2003), 2015, Aug-07, Volume: 44, Issue:29

    Topics: Aniline Compounds; Antineoplastic Agents; Cell Proliferation; Drug Screening Assays, Antitumor; ErbB Receptors; HeLa Cells; Humans; Models, Molecular; Neoplasms; Organometallic Compounds; Quinazolines; Ruthenium

2015
Rh(III)-catalyzed [5+1] oxidative cycloaddition of arylguanidines with alkynes: a novel access to C4-disubstituted 1,4-dihydroquinazolin-2-amines.
    Chemical communications (Cambridge, England), 2015, Oct-21, Volume: 51, Issue:82

    Topics: Alkynes; Catalysis; Cycloaddition Reaction; Guanidines; Models, Chemical; Quinazolines; Ruthenium

2015
Discovery of a dual-targeting organometallic ruthenium complex with high activity inducing early stage apoptosis of cancer cells.
    Metallomics : integrated biometal science, 2015, Volume: 7, Issue:12

    Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Drug Delivery Systems; Humans; Hydrolysis; Molecular Docking Simulation; Organometallic Compounds; Quinazolines; Ruthenium

2015
Synthesis, Characterization, and in Vitro Antitumor Activity of Ruthenium(II) Polypyridyl Complexes Tethering EGFR-Inhibiting 4-Anilinoquinazolines.
    Inorganic chemistry, 2016, 05-02, Volume: 55, Issue:9

    Topics: 2,2'-Dipyridyl; Aniline Compounds; Antineoplastic Agents; Apoptosis; Benzimidazoles; Cell Line, Tumor; Cisplatin; Coordination Complexes; DNA; ErbB Receptors; Fluorescent Dyes; Gefitinib; Humans; Hydrolysis; Ligands; Membrane Proteins; Phenanthrolines; Quinazolines; Ruthenium

2016
A novel microemulsion-based isotonic perfusate modulated by Ringer's solution for improved microdialysis recovery of liposoluble substances.
    Journal of nanobiotechnology, 2018, Nov-14, Volume: 16, Issue:1

    Topics: Animals; Drug Carriers; Emulsions; Fibroblasts; Humans; Isotonic Solutions; Lipids; Male; Membranes, Artificial; Microdialysis; Nanoparticles; Oleic Acids; Particle Size; Perfusion; Polyethylene Glycols; Quinazolines; Rats, Sprague-Dawley; Ringer's Solution; Ruthenium; Skin Absorption; Solubility; Surface-Active Agents

2018
Synthesis of Quinazoline and Quinazolinone Derivatives via Ligand-Promoted Ruthenium-Catalyzed Dehydrogenative and Deaminative Coupling Reaction of 2-Aminophenyl Ketones and 2-Aminobenzamides with Amines.
    Organic letters, 2019, 05-03, Volume: 21, Issue:9

    Topics: Amines; Benzamides; Catalysis; Coordination Complexes; Cycloaddition Reaction; Ketones; Ligands; Quinazolines; Quinazolinones; Ruthenium

2019
A Novel Conjugate of Bis[((4-bromophenyl)amino)quinazoline], a EGFR-TK Ligand, with a Fluorescent Ru(II)-Bipyridine Complex Exhibits Specific Subcellular Localization in Mitochondria.
    Molecular pharmaceutics, 2019, 10-07, Volume: 16, Issue:10

    Topics: Cell Proliferation; Colonic Neoplasms; ErbB Receptors; Extranodal Extension; Fluorescent Dyes; Glioblastoma; Humans; Mitochondria; Protein Kinase Inhibitors; Quinazolines; Ruthenium; Subcellular Fractions

2019